|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 24.06 EUR | +0.59% |
|
-2.55% | +3.53% |
| 07-09 | GSK adds Royal Philips' Chief Executive Jakobs to board | AN |
| 07-08 | Royal Philips Introduces Alturion Ultrasound System With AI-Powered Workflows For High-Volume Clinical Environments | CI |
| Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 1.76 | -0.17 | 0.87 | 2.01 | 3.2 | |||||
Return on Total Capital | 2.56 | -0.25 | 1.26 | 2.98 | 4.62 | |||||
Return On Equity % | 4.64 | -11.66 | -3.58 | -6.98 | 7.82 | |||||
Return on Common Equity | 4.62 | -11.71 | -3.61 | -7.02 | 7.83 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 42.1 | 40.35 | 40.99 | 43.13 | 45.18 | |||||
SG&A Margin | 27.54 | 29.67 | 28.36 | 28.23 | 27.96 | |||||
EBITDA Margin % | 8.56 | 3.75 | 6.2 | 8.85 | 11.3 | |||||
EBITA Margin % | 6.37 | 1.25 | 3.89 | 6.59 | 9.21 | |||||
EBIT Margin % | 4.81 | -0.48 | 2.3 | 5.21 | 8.02 | |||||
Income From Continuing Operations Margin % | 3.57 | -9.08 | -2.5 | -4.67 | 5.05 | |||||
Net Income Margin % | 19.35 | -9.02 | -2.56 | -3.9 | 5.02 | |||||
Net Avail. For Common Margin % | 3.54 | -9.09 | -2.51 | -4.68 | 5.04 | |||||
Normalized Net Income Margin | 2.5 | -1.02 | 0.17 | 1.95 | 4.31 | |||||
Levered Free Cash Flow Margin | 8.39 | -3.37 | 12.94 | 7.75 | 2.54 | |||||
Unlevered Free Cash Flow Margin | 8.94 | -2.55 | 13.92 | 8.68 | 3.49 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 0.58 | 0.58 | 0.6 | 0.62 | 0.64 | |||||
Fixed Assets Turnover | 6.38 | 6.68 | 7.1 | 7.3 | 7.64 | |||||
Receivables Turnover (Average Receivables) | 4.29 | 4.47 | 4.56 | 4.68 | 4.72 | |||||
Inventory Turnover (Average Inventory) | 3.08 | 2.84 | 2.84 | 3.06 | 3.22 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 1.39 | 1.29 | 1.2 | 1.23 | 1.32 | |||||
Quick Ratio | 0.88 | 0.74 | 0.74 | 0.8 | 0.9 | |||||
Operating Cash Flow to Current Liabilities | 0.68 | -0.02 | 0.27 | 0.19 | 0.15 | |||||
Days Sales Outstanding (Average Receivables) | 85.17 | 81.62 | 80.01 | 78.22 | 77.26 | |||||
Days Outstanding Inventory (Average Inventory) | 118.38 | 128.71 | 128.35 | 119.45 | 113.28 | |||||
Average Days Payable Outstanding | 70.1 | 62.39 | 69.76 | 68.88 | 72.57 | |||||
Cash Conversion Cycle (Average Days) | 133.44 | 147.94 | 138.6 | 128.79 | 117.97 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 48.22 | 61.74 | 63.75 | 63.43 | 73.57 | |||||
Total Debt / Total Capital | 32.53 | 38.17 | 38.93 | 38.81 | 42.39 | |||||
LT Debt/Equity | 44.72 | 54.73 | 58.33 | 59.06 | 63.1 | |||||
Long-Term Debt / Total Capital | 30.17 | 33.84 | 35.62 | 36.14 | 36.35 | |||||
Total Liabilities / Total Assets | 53.25 | 56.72 | 58.98 | 58.44 | 59.22 | |||||
EBIT / Interest Expense | 5.43 | -0.36 | 1.46 | 3.5 | 5.28 | |||||
EBITDA / Interest Expense | 11.32 | 3.77 | 4.66 | 6.7 | 8.14 | |||||
(EBITDA - Capex) / Interest Expense | 8.71 | 1.88 | 3.45 | 5.52 | 7.15 | |||||
Total Debt / EBITDA | 4.06 | 9.29 | 5.79 | 4.25 | 3.67 | |||||
Net Debt / EBITDA | 2.72 | 7.95 | 4.38 | 2.92 | 2.4 | |||||
Total Debt / (EBITDA - Capex) | 5.27 | 18.68 | 7.82 | 5.16 | 4.17 | |||||
Net Debt / (EBITDA - Capex) | 3.53 | 15.99 | 5.92 | 3.54 | 2.73 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | -0.91 | 3.91 | 1.92 | -0.81 | -1.04 | |||||
Gross Profit, 1 Yr. Growth % | -9.14 | -0.4 | 3.53 | 4.36 | 3.67 | |||||
EBITDA, 1 Yr. Growth % | -39.47 | -53.15 | 68.46 | 41.44 | 26.47 | |||||
EBITA, 1 Yr. Growth % | -46.1 | -79.31 | 218.47 | 68.03 | 38.3 | |||||
EBIT, 1 Yr. Growth % | -52.61 | -110.51 | -590.59 | 125.18 | 52.4 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | -38.74 | -364.38 | -71.94 | 85.24 | -207.02 | |||||
Net Income, 1 Yr. Growth % | 179.61 | -148.45 | -71.02 | 50.64 | -227.49 | |||||
Normalized Net Income, 1 Yr. Growth % | -55.87 | -143.45 | -116.72 | 1.05K | 118.47 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | -37.96 | -374.61 | -71.59 | 88.05 | -202.85 | |||||
Accounts Receivable, 1 Yr. Growth % | -7.41 | 7.14 | -6.84 | 0.49 | -4.56 | |||||
Inventory, 1 Yr. Growth % | 15.27 | 17.36 | -13.78 | -8.39 | -10.26 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | 0.63 | -2.26 | -5.88 | -1.25 | -9.58 | |||||
Total Assets, 1 Yr. Growth % | 11.72 | -0.88 | -4.18 | -1.46 | -7.01 | |||||
Tangible Book Value, 1 Yr. Growth % | -49.39 | -116.27 | 475.41 | 34.05 | -59.4 | |||||
Common Equity, 1 Yr. Growth % | 21.63 | -8.24 | -9.22 | -0.18 | -8.74 | |||||
Cash From Operations, 1 Yr. Growth % | 90.61 | -103.68 | -1.32K | -31.12 | -25.32 | |||||
Capital Expenditures, 1 Yr. Growth % | -18.14 | 11.84 | -22.3 | -8.12 | -15.14 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | -11.26 | -145.14 | -490.85 | -41 | -67.54 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | -10.89 | -131.84 | -655.59 | -38.11 | -60.18 | |||||
Dividend Per Share, 1 Yr. Growth % | 0 | - | - | - | 0 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | 0.03 | 1.47 | 2.91 | 0.54 | -0.93 | |||||
Gross Profit, 2 Yr. CAGR % | -4.67 | -4.65 | 1.93 | 3.95 | 4.01 | |||||
EBITDA, 2 Yr. CAGR % | -25.18 | -50.7 | -12.26 | 34.05 | 33.69 | |||||
EBITA, 2 Yr. CAGR % | -26.37 | -67.19 | -7.98 | 159.81 | 52.34 | |||||
EBIT, 2 Yr. CAGR % | -30.74 | -77.54 | -9.84 | 124.08 | 85.03 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | -21.34 | 27.26 | -13.87 | -27.9 | 40.8 | |||||
Net Income, 2 Yr. CAGR % | 68.64 | 16.39 | -62.53 | -33.93 | 38.59 | |||||
Normalized Net Income, 2 Yr. CAGR % | -34.38 | -55.96 | -63.95 | 19.59 | 402.13 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | -20.49 | 30.53 | -11.61 | -27.13 | 39.07 | |||||
Accounts Receivable, 2 Yr. CAGR % | -7.79 | -0.4 | -0.09 | -3.24 | -2.04 | |||||
Inventory, 2 Yr. CAGR % | 11.54 | 16.31 | 0.59 | -11.13 | -9.33 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | -2.96 | -0.82 | -4.08 | -3.59 | -5.51 | |||||
Total Assets, 2 Yr. CAGR % | 7.05 | 5.23 | -2.54 | -2.83 | -4.28 | |||||
Tangible Book Value, 2 Yr. CAGR % | -16.29 | -71.29 | -3.25 | 177.72 | -26.23 | |||||
Common Equity, 2 Yr. CAGR % | 7.06 | 5.65 | -8.73 | -4.81 | -4.56 | |||||
Cash From Operations, 2 Yr. CAGR % | 62.27 | -73.53 | -33 | 190.01 | -28.28 | |||||
Capital Expenditures, 2 Yr. CAGR % | -9.62 | -4.32 | -6.78 | -15.5 | -11.7 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | 48.67 | -40.55 | 34.72 | 105 | -56.27 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | 42.15 | -49.82 | 34.75 | 185.58 | -50.39 | |||||
Dividend Per Share, 2 Yr. CAGR % | - | - | - | - | 0 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | -1.81 | 1.3 | 1.62 | 1.65 | 0.01 | |||||
Gross Profit, 3 Yr. CAGR % | -5.87 | -3.27 | -1.99 | 2.74 | 3.85 | |||||
EBITDA, 3 Yr. CAGR % | -18.86 | -36.59 | -25.74 | 2.88 | 31.48 | |||||
EBITA, 3 Yr. CAGR % | -22.12 | -52.05 | -30.01 | 12.47 | 110.56 | |||||
EBIT, 3 Yr. CAGR % | -25.12 | -63.3 | -37.22 | 22.33 | 97.06 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | -22.41 | 17.83 | -23.12 | 11.18 | -17.76 | |||||
Net Income, 3 Yr. CAGR % | 44.94 | 11.28 | -26.78 | -40.42 | -17.74 | |||||
Normalized Net Income, 3 Yr. CAGR % | -27.48 | -43.26 | -68.11 | 14.46 | 46.19 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | -21.21 | 20.18 | -21.5 | 12.53 | -18.26 | |||||
Accounts Receivable, 3 Yr. CAGR % | 0.38 | -3.06 | -2.59 | 0.1 | -3.66 | |||||
Inventory, 3 Yr. CAGR % | 8.86 | 13.45 | 5.26 | -2.5 | -10.84 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 21.39 | -2.73 | -2.54 | -3.15 | -5.63 | |||||
Total Assets, 3 Yr. CAGR % | 5.97 | 4.34 | 2 | -2.18 | -4.24 | |||||
Tangible Book Value, 3 Yr. CAGR % | 6.73 | -51.49 | -22.01 | 7.86 | 46.3 | |||||
Common Equity, 3 Yr. CAGR % | 6.1 | 1.7 | 0.44 | -5.97 | -6.14 | |||||
Cash From Operations, 3 Yr. CAGR % | 27.51 | -54.08 | -5.06 | -32.38 | 84.51 | |||||
Capital Expenditures, 3 Yr. CAGR % | -2.02 | -2.97 | -10.73 | -7.23 | -15.38 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | -17.44 | -2.6 | 11.37 | 2.57 | 10.86 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | -16.76 | -15.67 | 11.85 | 3.96 | 48.03 | |||||
Dividend Per Share, 3 Yr. CAGR % | 0.67 | - | - | 1.75 | - | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | -0.31 | 0.05 | 0.05 | 1 | 0.59 | |||||
Gross Profit, 5 Yr. CAGR % | -1.93 | -2.73 | -2.97 | -0.44 | 0.37 | |||||
EBITDA, 5 Yr. CAGR % | -9.08 | -22.85 | -16.34 | -9.49 | -6.03 | |||||
EBITA, 5 Yr. CAGR % | -10.78 | -35.63 | -21.1 | -10.02 | -4.44 | |||||
EBIT, 5 Yr. CAGR % | -13.34 | -45.38 | -26.66 | -11.4 | -3.22 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | -5.93 | 9.5 | -19.1 | -3.19 | -2.07 | |||||
Net Income, 5 Yr. CAGR % | 18.04 | -0.6 | -15.63 | -9.67 | -5.49 | |||||
Normalized Net Income, 5 Yr. CAGR % | -13.46 | -25.8 | -51.42 | -18.82 | -3.94 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | -4.25 | 16.95 | -17.54 | -2.11 | -1.93 | |||||
Accounts Receivable, 5 Yr. CAGR % | -6.29 | 1.08 | 0.19 | -3.13 | -2.37 | |||||
Inventory, 5 Yr. CAGR % | 0.34 | 11.47 | 5.48 | 2.89 | -0.84 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 6.43 | 12.7 | 10.47 | -3.07 | -3.74 | |||||
Total Assets, 5 Yr. CAGR % | -0.82 | 3.92 | 2.48 | 1.41 | -0.56 | |||||
Tangible Book Value, 5 Yr. CAGR % | 3.42 | -39.71 | 2.65 | -2.52 | -23.73 | |||||
Common Equity, 5 Yr. CAGR % | 2.85 | 2 | -0.1 | -0.96 | -1.59 | |||||
Cash From Operations, 5 Yr. CAGR % | 8.67 | -42.46 | -1.42 | -4.03 | -15.14 | |||||
Capital Expenditures, 5 Yr. CAGR % | 1.98 | 1.12 | -3.95 | -8.19 | -11.12 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | 6.69 | -21.64 | -1.66 | 16.51 | -23.25 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | 4.6 | -26.7 | -1 | 15.57 | -19.2 | |||||
Dividend Per Share, 5 Yr. CAGR % | 1.63 | - | - | - | 1.05 |
- Stock Market
- Stocks
- PHIA Stock
- Financials Philips NV
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















